"Our BIO membership connects us with key stakeholders who are collaborating to improve outcomes for patients. As we work to develop transformative therapies, it is critical that these therapies get to the patients who need them. Our work with BIO has enabled us to advocate for policies to improve access to our medicines."
Ameet Mallik
Executive Vice President, Head of U.S.
Novartis Oncology